Phase Zero: The Diagnostic PE Portfolio Companies Need Before Spending Another Dollar

What to Diagnose Before Your Private Equity 100-Day Plan

Phase Zero is TBM’s four-step diagnostic that pinpoints and sizes the value creation levers private equity relies on in a portfolio company — in weeks, before the private equity 100-day plan locks in a direction. It clarifies the main value creation levers in private equity and prepares a fact-based roadmap to operational improvements, revenue growth, cost optimization, and margin expansion.

You Don’t Have a Value Creation Problem. You Have a Visibility Problem.

Deal volume is down — H1 2026 manufacturing deal value was the weakest half-year since 2020. When exits slow, value must come from inside the portfolio company. Most private equity 100-day plan blueprints are built on instinct, not data, and a wrong guess burns weeks a holding period doesn’t have. Phase Zero replaces the guess with a prioritized, dollar-sized list of value creation levers private equity can activate before the plan is written. By surfacing operational improvements and quantifying them, Phase Zero ensures the private equity 100-day plan targets the highest impact levers.

“You don’t need three months to test a hunch about what’s broken. You need about two weeks, the right data, and a team willing to be surgical instead of comprehensive.”

What’s Inside the Playbook

• The four-step Phase Zero diagnostic: scope and align, structured data request, financial and operational analysis, on-site validation. This sequence builds a fact base for the private equity 100-day plan and ensures the right value creation levers private equity needs are prioritized.
• The data behind it: why operational improvement — not leverage — drives most PE value creation, and how margin expansion and cost optimization reinforce sustainable gains.
• Three case studies: a 16-plant network diagnostic (~$4.8M identified), a single-plant diagnostic ($4.9M in two weeks), and a capacity diagnostic that fed a successful exit — each showing how value creation levers private equity activates can be sized and sequenced quickly.
• Industry-specific levers: for engineer-to-order, process, and service-oriented portfolio companies, with targeted operational improvements, revenue growth tactics, and cost optimization paths that enable margin expansion.
• A 30/60/90-day cadence: to turn findings into tracked results inside year one, aligning leadership to the private equity 100-day plan and reinforcing accountability on each lever.

Why TBM

Most firms diagnose, hand over a report, and leave the portfolio company’s team to execute it. TBM stays on the ground through the diagnostic and the implementation — the partner a PE firm can trust to explain what’s actually going on and build a plan to create value inside the holding period. We link operational improvements to revenue growth, cost optimization, and margin expansion so that the value creation levers private equity depends on are executed with discipline and measured against the private equity 100-day plan milestones. Learn more about TBM’s Private Equity Practice. 

Complete the form to the right to access the full Phase Zero playbook to see how a data-driven private equity 100-day plan, anchored in the proven value creation levers private equity applies, accelerates results and de-risks execution from day one.